ODDITY Tech saw its IBD SmartSelect Composite Rating rise to 96 Wednesday, up from 94 the day before.
Lean How — And When — To Sell Stocks
The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.
ODDITY Tech is now out of buy range after clearing the 51.00 buy point in a consolidation.
The stock sports a 93 EPS Rating, which means its recent quarterly and annual earnings growth is outpacing 93% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company posted 12% earnings growth for Q2. Top line growth came in at 25%, down from 27% in the prior quarter.
ODDITY Tech holds the No. 1 rank among its peers in the Cosmetics/Personal Care industry group. Lifevantage and Nature's Sunshine are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
